Home » Topics » BioWorld Science

BioWorld Science
RSS

Microrod formulation of travoprost provides sustained release

May 3, 2018

Arixa completes seed financing to advance oral avibactam prodrug ARX-1796

May 3, 2018

FDA grants fast track designation to RGX-121 gene therapy

May 3, 2018

Hanmi opens first-in-human trial of HM-15211 in healthy obese subjects

May 3, 2018

Lycera updates on ROR-gamma agonists LYC-54143 and LYC-55716

May 3, 2018

Patient enrollment ongoing in phase I study of CSJ-117 in atopic asthma

May 3, 2018

MOR-106 moves into phase II development for atopic dermatitis with IGUANA trial

May 3, 2018

NeoImmuneTech enters clinical trial collaboration with Roche

May 3, 2018

FDA grants rare pediatric disease designation to CLR-131 for neuroblastoma

May 3, 2018

Millennium Pharmaceuticals initiates first-in-human trial of TAK-164

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...